Year None202320222021202020192018201720162015201420132012 04.02.2020 Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 03.23.2020 Iveric Bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer 03.18.2020 Iveric Bio Provides Update on the Initiation of the Second Pivotal Clinical Trial Enrollment for Zimura® in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration 03.03.2020 Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 02.27.2020 Iveric Bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results 02.26.2020 Iveric Bio to Present at the Cowen and Company 40th Annual Health Care Conference 02.20.2020 Iveric Bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020 01.13.2020 Iveric Bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration 12.19.2019 Iveric Bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA 12.19.2019 Iveric Bio to Present at the 38th Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page next › Last page last »